Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 589
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02716974 | A Study of Definitive Therapy to Treat Prostate Cancer | ||
| NCT00897273 | Oral HPV Infection in Young Men | ||
| NCT07424222 | Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE) | ||
| NCT00134017 | Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer | ||
| NCT01496157 | Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer | ||
| NCT02644291 | Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors | ||
| NCT02965755 | Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins | ||
| NCT07375992 | Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM) | ||
| NCT02146937 | A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance | ||
| NCT03707457 | Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma | ||
| NCT07430202 | A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) | ||
| NCT02875002 | Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas | ||
| NCT03250273 | A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma | ||
| NCT00265902 | Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's Sarcoma | ||
| NCT01578551 | Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. | ||
| NCT00982319 | Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue | ||
| NCT03523299 | Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer | ||
| NCT01447771 | Decision Support for Women With Breast Cancer | ||
| NCT00003414 | Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease | ||
| NCT02048384 | A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer | ||
| NCT02657850 | Head and Neck Cancer Treatment Related Dysphagia | ||
| NCT06922318 | The COSMYC Trial (COmbined Suppression of MYC) | ||
| NCT01045460 | Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma | ||
| NCT07140315 | DK222 Study at Hopkins | ||
| NCT07209176 | Physician- and Patient-based Barriers to NGS Testing | ||
| NCT01732640 | A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. | ||
| NCT07071155 | Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia | ||
| NCT05103722 | Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma | ||
| NCT00559429 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer | ||
| NCT01372202 | CHFR Methylation Status Esophageal Cancer Study | ||
| NCT05574712 | A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer | ||
| NCT02420977 | Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer | ||
| NCT01282216 | Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide | ||
| NCT00238277 | Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme | ||
| NCT07360119 | Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors | ||
| NCT06826924 | 7-Days Water-Only Fasting Trial in Prostate Cancer | ||
| NCT02743910 | Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer | ||
| NCT02845323 | Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder | ||
| NCT04363164 | Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression | ||
| NCT00003289 | UCN-01 in Treating Patients With Advanced Cancer | ||
| NCT00004868 | SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy | ||
| NCT01480050 | Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma | ||
| NCT00404248 | Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma | ||
| NCT00100828 | Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer | ||
| NCT03051477 | Trial of Mistletoe Extract in Patients With Advanced Solid Tumors | ||
| NCT02431676 | Survivorship Promotion In Reducing IGF-1 Trial | ||
| NCT00238368 | Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant | ||
| NCT03044613 | Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer | ||
| NCT01900496 | Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma | ||
| NCT00895180 | Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme |
